Ursodeoxycholic Acid (UDCA) and Preventing Gallstones After Rapid Weight Loss

Gallstone disease (cholelithiasis) is the presence of hardened deposits in the gallbladder, forming mainly when bile contains too much cholesterol relative to the bile salts and lecithin that normally keep it dissolved. When that balance is disrupted, cholesterol starts to precipitate and crystallize, gradually forming hard stones. Most gallstones cause no symptoms for a long time, but in some people they lead to severe pain in the upper right abdomen (so-called biliary colic), nausea, and in complicated cases to inflammation of the gallbladder or bile ducts requiring urgent surgical intervention.

Many risk factors for gallstones are well known — female sex, age, obesity, pregnancy, certain medications, and genetic predisposition. One factor, however, is often left out of conversations about weight loss, despite being well documented for decades: rapid, large weight loss itself can significantly raise the risk of new stones forming, regardless of the method used to achieve that loss.

The mechanism behind this is well established in physiology and stems from what happens in the liver during intense mobilization of fat tissue. When the body burns large amounts of fat in a short time — as happens after bariatric surgery or on very restrictive low-calorie diets (below roughly 800 kcal/day) — a sudden, increased stream of cholesterol released from breaking-down fat cells reaches the liver. The liver secretes this excess cholesterol into bile faster than the secretion of bile salts, which normally keep it in solution, can keep pace. The result is bile supersaturated with cholesterol — a state that favors crystallization and stone formation.

An additional factor is that with very low calorie intake, and especially low dietary fat, the gallbladder contracts and empties less often (because gallbladder contraction is triggered mainly by fat in food). Bile stays in the gallbladder longer, giving supersaturated cholesterol more time to crystallize. This combination — more cholesterol in bile and less frequent gallbladder emptying — explains why gallstone risk rises so markedly specifically with rapid, large weight reduction, rather than with gradual, moderate weight loss.

The number of bariatric procedures (including gastric bypass and sleeve gastrectomy) is rising year after year as an effective treatment for severe obesity and its accompanying metabolic diseases. Patients after such procedures typically lose anywhere from a dozen to several dozen kilograms within the first 6-12 months — it's precisely the pace and scale of this loss that makes the post-bariatric population one of the groups with the highest documented risk of newly formed gallstones, reaching as high as 30-50% in the first year after surgery in observational studies without any prophylaxis.

It's precisely in this specific population — not in the general population of people losing weight through diet and physical activity at a typical, moderate pace — that researchers have for years studied whether prophylactic administration of ursodeoxycholic acid (UDCA), a naturally occurring bile acid with cholesterol-dissolving action, can prevent new stones from forming. We describe one of the newer, well-designed studies in this area below.

In other words: this study answers a narrow, specific clinical question (does UDCA help a particular group of post-surgical patients) and should be interpreted only in that context. The decision to use UDCA after bariatric surgery is made by the surgical/bariatric team caring for the patient, taking individual risk factors into account — not by the patient alone based on a single article or an internet search.

This study's results are promising and show that in a narrow, well-defined population — bariatric surgery patients whose gallstone risk is already dramatically elevated by the nature of the procedure itself — a simple, six-month pharmacological intervention can significantly reduce the number of complications that sometimes require another operation. This is important information for the growing number of people undergoing bariatric surgery and for the teams who care for them.

This is not, however, a signal to treat UDCA as a universal "add-on" to every weight-loss diet. For the vast majority of people reducing their body weight at a typical, gradual pace, the best known gallstone prophylaxis remains avoiding excessively rapid weight loss — not reaching for a medication reserved for a completely different, much higher-risk group of patients.